Source: Annual Congress 2004 - Drug therapy of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Bruni, S. Granieri, A. Bruni (Cosenza, Italy). How the bronchodilatator in COPD patients works. Eur Respir J 2004; 24: Suppl. 48, 1869

Member's Comments

No comment yet.

Related content which might interest you: Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020 A new budesonide/formoterol inhalation therapy in patients with asthma, COPD and ACOS Source: International Congress 2017 – Bronchial asthma management Year: 2017 Bronchodilator efficacy of tiotropium in patients with mild COPD Source: Eur Respir J 2006; 28: Suppl. 50, 616s Year: 2006 Evaluation of bronchodilator responses in patients with advanced COPD Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001 Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Dual bronchodilation with once-daily QVA149 improves lung function and reduces exacerbations in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 The effect of inhaler switching on asthma and COPD patients Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Bronchodilator treatment for asthma and COPD Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010 QVA149 improves lung function and reduces exacerbations compared to tiotropium in patients with severe-to-very severe COPD: The SPARK study Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 A novel way of heliox administration in patients with COPD exacerbation Source: Annual Congress 2011 - Mechanical ventilation and weaning Year: 2011 Tiotropium in COPD patients Source: Breathe 2008; 5: 271 Year: 2009 COPD patients Source: Eur Respir Monogr 2021; 90: 154-164 Year: 2021 Care-continuity for COPD patients Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences Year: 2012 Evaluation of the individual bronchodilator response in patients with severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002 Bronchodilator responsiveness in patients with COPD Source: Eur Respir J 2008; 31: 742-750 Year: 2008 The effect of tiotropium in the treatment of patients with COPD Source: Annual Congress 2010 - COPD: management Year: 2010 QVA149 provides superior peak lung function in patients with COPD Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 240s Year: 2002 Baseline characteristics of COPD patients with frequent COPD exacerbations in tiotropium trials Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006